Vericel Corp. (NASDAQ: VCEL) Vericel Corp Spikes On News Of FDA Approval On Wednesday before the market opened, shares of VCEL, a leading developer in autologous cell therapies, were being bought up on volume following the announcement that the Food & Drug Administration (FDA) has approved MACI for the treatment of symptomatic cartilage defects in the knee's of adults. … [Read more...]
Vericel (VCEL) Stock Climbs on Solid Phase 2b Data!
Vericel Corp (NASDAQ: VCEL)Vericel is having an incredible day in the market today after a key announcement the company made yesterday. The announcement surrounded one of the company's lead drug candidates and the results of that candidate in Phase 2b trials. Today, we'll take a look at the results, how the market reacted to the news, and what we can expect to see from VCEL … [Read more...]
